Lamivudine
NDC 64330-001
Product Information
Lamivudine is a ANDA-approved product labeled by Centaur Pharmaceuticals Private Limited. This drug is used with other HIV medications to help control HIV infection. It is supplied as a white product. This product entry covers the primary NDC 64330-001 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
001
Code Structure Chart
Product Details
What is NDC 64330-001?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- LAMIVUDINE (UNII: 2T8Q726O95)
- LAMIVUDINE (UNII: 2T8Q726O95) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- WATER (UNII: 059QF0KO0R)
- HYPROMELLOSE 2910 (6 MPA.S) (UNII: 0WZ8WG20P6)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)
- POLYSORBATE 80 (UNII: 6OZP39ZG8H)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 199147 - lamiVUDine 150 MG Oral Tablet
- RxCUI: 199147 - lamivudine 150 MG Oral Tablet
- RxCUI: 199147 - 3TC 150 MG Oral Tablet
* Please review the full disclaimer at the bottom of this page.